OXLUMO
Live / Registered — Registered (as of 09 Mar 2021)
What this means for you
Registered since 09 Mar 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88576813
- Registration number
- 6290281
- Mark type
- Design + words
- Filed
- 13 Aug 2019
- Published for opposition
- 15 Oct 2019
- Registered
- 09 Mar 2021
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of primary hyperoxaluria
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 09 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Feb 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Feb 2021 — ASSIGNED TO EXAMINER
- 24 Jan 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jan 2021 — USE AMENDMENT FILED
- 24 Jan 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jan 2021 — TEAS STATEMENT OF USE RECEIVED
- 04 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2020 — SOU EXTENSION 2 GRANTED
- 02 Dec 2020 — SOU EXTENSION 2 FILED
- 02 Dec 2020 — SOU TEAS EXTENSION RECEIVED
- 02 Jun 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2020 — SOU EXTENSION 1 GRANTED